| Patents for A61K 9 - Medicinal preparations characterised by special physical form (299,044) |
|---|
| 05/26/2006 | WO2005053727A3 Pharmaceutical compositions for bioactive peptide agents |
| 05/26/2006 | WO2005020880A3 Methods for the treatment of endometriosis |
| 05/26/2006 | WO2004027383A3 System and method to stress test aerosol inhalation devices |
| 05/26/2006 | CA2588509A1 Production of double- or multi-layered microcapsules |
| 05/26/2006 | CA2588433A1 Steroid formulation and methods of treatment using same |
| 05/26/2006 | CA2588400A1 Enteric coated bead comprising ixabepilone, and preparation thereof |
| 05/26/2006 | CA2588215A1 Controlled absorption of statins in the intestine |
| 05/26/2006 | CA2588044A1 Ophthalmic compositions and methods for treating eyes |
| 05/26/2006 | CA2587741A1 Method for loading multiple agents into delivery vehicles |
| 05/26/2006 | CA2587734A1 Exfoliating skin care product |
| 05/26/2006 | CA2587731A1 Anti-inflammatory extract and agent and method for the production thereof |
| 05/26/2006 | CA2587710A1 Injectable nanoparticulate olanzapine formulations |
| 05/26/2006 | CA2587411A1 Sirna silencing of apolipoprotein b |
| 05/26/2006 | CA2586742A1 Process and device for producing finely divided liquid-liquid formulations, and the uses of these liquid-liquid formulations |
| 05/26/2006 | CA2586395A1 Methods to produce lung surfactant formulations via lyophilization and formulations and uses thereof |
| 05/26/2006 | CA2585363A1 Taste-masked multiparticulate pharmaceutical compositions comprising a drug-containing core particle and a solvent-coacervated membrane |
| 05/26/2006 | CA2584673A1 Methods of treating cancer with lipid-based platinum compound formulations administered intraperitoneally |
| 05/26/2006 | CA2584343A1 Pharmaceutical compositions comprising a camptothecin derivate |
| 05/26/2006 | CA2581814A1 Stable tablet formulation of tetrahydrobiopterin |
| 05/26/2006 | CA2528191A1 Novel formulation of pyridoxal 5'-phosphate and method of preparation |
| 05/25/2006 | US20060111693 Minimally compliant, volume-efficient piston for osmotic drug delivery systems |
| 05/25/2006 | US20060111692 Robotically controlled intravascular tissue injection system |
| 05/25/2006 | US20060111397 Methods and compositions for treating diseases associated with excesses in ACE |
| 05/25/2006 | US20060111356 External preparation for allergic diseases |
| 05/25/2006 | US20060111354 Medicaments containing vardenafil hydrochloride trihydrate |
| 05/25/2006 | US20060111315 Method for inhibition of pathogenic microorganisms |
| 05/25/2006 | US20060111300 Antimicrobial amino acid sequences derived from alpha-melanocyte-stimulating hormone |
| 05/25/2006 | US20060111292 Using gene-regulatory peptide |
| 05/25/2006 | US20060110596 Hot melt adhesives for medical application |
| 05/25/2006 | US20060110517 Novel compositions comprising carotenoids |
| 05/25/2006 | US20060110465 Compositions addressing inflammation and/or degenerative disorders |
| 05/25/2006 | US20060110464 Material encapsulation system |
| 05/25/2006 | US20060110463 Oral pharmaceutical formulation in the form of aqueous suspension of microcapsules for modified release of amoxicillin |
| 05/25/2006 | US20060110462 Nanoparticulate compositions of tubulin inhibitor compounds |
| 05/25/2006 | US20060110461 Non-food and non-pharmaceutical use of a selected anhydrous dextrose composition |
| 05/25/2006 | US20060110460 dissolving active principle in water; emulsifying resulting solution of active principle with d,l-lactide-co-glycolide matrix copolymer, emulsifying first emulsion in external aqueous phase containing surfactant, viscosity-enhancing agent, osmotic agent, extraction-evaporation to form microspheres |
| 05/25/2006 | US20060110459 Triple natural polymer viscoelastic composition |
| 05/25/2006 | US20060110458 Sustained release drug carrier |
| 05/25/2006 | US20060110457 Heat cured gel and method of making |
| 05/25/2006 | US20060110456 Method for biocidal and/or biostatic treatment and compositions therefor |
| 05/25/2006 | US20060110455 Dosage forms of antiviral and a carrier; an immediate release dosage form and delayed release dosages, each initiates release at different times; product contains the total dosage of the antiviral for a twenty-four hour period |
| 05/25/2006 | US20060110454 Extended release formulation of pramipexole dihydrochloride |
| 05/25/2006 | US20060110453 Calcium hypochlorite blended tablets |
| 05/25/2006 | US20060110452 Dosage forms of risedronate |
| 05/25/2006 | US20060110451 Formulations of [1,4]diazepino[6,7,1-IJ]quinoline derivatives |
| 05/25/2006 | US20060110450 Bilayer tablet of telmisartan and amlodipine |
| 05/25/2006 | US20060110449 Pharmaceutical composition |
| 05/25/2006 | US20060110448 Combination of a macrolide and a local anesthetic for the treatment of dermatological diseases |
| 05/25/2006 | US20060110447 Controlled and continued delivery of rifaximin and/or other substances |
| 05/25/2006 | US20060110446 Deferacirox dispersible tablets |
| 05/25/2006 | US20060110445 Dispersible tablet for oral administration |
| 05/25/2006 | US20060110444 Gemfibrozil, fenofibrate, bezafibrate, clofibrate, ciprofibrate and active metabolites and analogues dissolved in a vehicle, which is hydrophobic, hydrophilic or water-miscible; improved bioavailability of the active ingredient upon oral administration |
| 05/25/2006 | US20060110443 toxic or potent core is incorporated into the dosage form via three-dimensional printing, as a solution, solubilization or suspension of solid particles in liquid, rather than by the more conventional handling and compressing of dry powder; allows greater bioavailability |
| 05/25/2006 | US20060110442 Coated sherical seamless filled capsules |
| 05/25/2006 | US20060110441 Lyophilized liposome formulations and method |
| 05/25/2006 | US20060110440 Method and system for biasing cellular development |
| 05/25/2006 | US20060110439 Dermal delivery of n-methyl-glucamine and n-methyl-glucamine compounds |
| 05/25/2006 | US20060110438 Liposome stabilizing agent |
| 05/25/2006 | US20060110437 Synthesis and self-assembly of abc triblock bola peptide |
| 05/25/2006 | US20060110436 Phospholipid derivative |
| 05/25/2006 | US20060110435 Allergy vaccine composition, production method thereof and use of same in allergy treatment |
| 05/25/2006 | US20060110433 Adhesive patch |
| 05/25/2006 | US20060110432 Lotion-treated tissue and towel |
| 05/25/2006 | US20060110431 Sheets having alternating areas of relatively high and low lotion add-on in the machine direction |
| 05/25/2006 | US20060110426 Cohesive coprecipitates of sulfated polysaccharide and fibrillar protein and use thereof |
| 05/25/2006 | US20060110425 Leech extracts for stents |
| 05/25/2006 | US20060110423 polyglycolic acid or polylactic acid or glycolic acid-lactic acid copolymer as biocompatible polymer having dispersed therein an active agent such as exendin-4; antidiabetic agent |
| 05/25/2006 | US20060110413 Novel Molecules dervied from noraporphine |
| 05/25/2006 | US20060110412 Vaccine composition |
| 05/25/2006 | US20060110409 Targeted agents for nerve regeneration |
| 05/25/2006 | US20060110402 Decolorized yeast cell wall fraction |
| 05/25/2006 | US20060110381 comprising a continuous, biocompatible liquid phase, a solid phase comprising porous or non-porous particles of a biocompatible polymer suitable for use in hemostasis and which are substantially insoluble in the liquid phase, and sterile thrombin |
| 05/25/2006 | US20060110379 Linkage of agents using microparticles |
| 05/25/2006 | US20060110356 Ophthalmic drug delivery system using polymer micelle |
| 05/25/2006 | US20060110343 Cosmetic or dermopharmaceutical compositions comprising tyramine derivatives, method for preparing same, and use thereof |
| 05/25/2006 | US20060110334 Two-compartment aerosol device comprising electrophilic monomers, and use thereof for the cosmetic treatment of the hair |
| 05/25/2006 | US20060110333 Composition for nasal absorption |
| 05/25/2006 | US20060110332 Agent for medicamentous treatment of acute and chronic pain |
| 05/25/2006 | US20060110331 Compositions comprising azelastine and methods of use thereof |
| 05/25/2006 | US20060110327 Methods and compositions for deterring abuse of orally administered pharmaceutical products |
| 05/25/2006 | US20060108229 Large volume ex vivo electroporation method |
| 05/25/2006 | US20060107904 Bovine germicide application device |
| 05/24/2006 | EP1659143A1 Temperature-responsive hydrogel |
| 05/24/2006 | EP1659142A1 Polyhydroxyalkanoate compositions having controlled degradation rates |
| 05/24/2006 | EP1658861A1 Active energy radiation hardenable skin plaster composition and skin plaster |
| 05/24/2006 | EP1658860A1 Drug compositions comprising anticholinergics and EGFR kinase inhibitors |
| 05/24/2006 | EP1658858A2 Use of botulinum toxin for the treatment of unstable bladder |
| 05/24/2006 | EP1658852A1 Oral pharmaceutical preparation containing ibandronat |
| 05/24/2006 | EP1658851A1 Anti-asthmatic combinations comprising surface active phospholipids |
| 05/24/2006 | EP1658842A1 Nanoparticles of polyoxyethylenated derivatives |
| 05/24/2006 | EP1658841A2 Tablet excipient |
| 05/24/2006 | EP1658840A1 Methods for fine powder formation |
| 05/24/2006 | EP1658839A1 Oligonucleotide/carrier combinations targeting CD40 |
| 05/24/2006 | EP1658105A2 Pharmaceutical metered dose inhaler and methods relating thereto |
| 05/24/2006 | EP1658103A1 Methods and devices for the treatment of intervertebral discs |
| 05/24/2006 | EP1658100A2 Particle-size reduction apparatus and use thereof |
| 05/24/2006 | EP1658089A2 Compositions for treating pathologies that necessitate suppression of gastric acid secretion |
| 05/24/2006 | EP1658086A2 Liposomes containing phosphate glycerol groups for treating acute inflammatory condition |
| 05/24/2006 | EP1658079A1 Multivitamin syrup for children or young adults |
| 05/24/2006 | EP1658063A1 Advantageous combinations for inhalation of nacystelyn and bronchodilators |